Future Market Insight predicts that the global Pharmacovigilance Market is poised to achieve a significant milestone, reaching an estimated value of US$ 23.31 billion by 2033. This projection indicates a remarkable CAGR of 13%. It’s worth noting that this anticipated value is substantially higher than the projected US$ 6.87 billion for 2023.
The global rise in chronic illnesses like diabetes, cancer, respiratory disorders, and cardiovascular diseases has resulted in a higher demand for medications and more extensive clinical trials to discover new drugs. Pharmacovigilance plays a critical role in ensuring drug safety and monitoring Adverse Drug Reactions (ADRs), leading to increased demand for pharmacovigilance services. Additionally, the market is expected to grow further due to academic efforts that promote pharmacovigilance.
The healthcare industry is increasingly emphasizing patient safety and patient-reported outcomes. Pharmacovigilance plays a crucial role in ensuring patient safety throughout the drug lifecycle. As healthcare stakeholders prioritize patient-centric care, the demand for effective pharmacovigilance measures increases.
Prepare To Thrive And Conquer New Horizons With Our Sample Report – Get It Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-1107
The growing use of pharmaceutical products and complex treatment regimens increases the likelihood of encountering adverse events. This necessitates an efficient pharmacovigilance system to promptly monitor, detect, and report adverse drug reactions. As the number of ADRs rises, pharmaceutical companies need to invest more in pharmacovigilance infrastructure, leading to market growth.
Regulatory agencies worldwide continuously update and enforce pharmacovigilance regulations to ensure patient safety. Pharmaceutical companies must comply with these requirements, leading to increased investments in pharmacovigilance infrastructure, processes, and technologies. The demand for pharmacovigilance solutions and services grows as companies strive to meet these stringent regulatory standards.
To manage the complexities of pharmacovigilance effectively, many pharmaceutical companies opt to outsource these tasks to specialized service providers. Outsourcing allows companies to access expertise, streamlined processes, and cost-effective solutions. The growing trend of outsourcing pharmacovigilance activities contributes to the expansion of the pharmacovigilance market.
The expanding number of drug development programs and clinical trials generates vast amounts of safety data. Pharmacovigilance is crucial during these phases to identify and manage potential risks to study participants and ensure drug safety. The demand for pharmacovigilance services increases as more drugs enter development and clinical testing stages.
With increasing global access to pharmaceutical products, drug consumption has risen significantly. This surge in usage requires a robust pharmacovigilance system to accurately monitor and report adverse events. As a result, pharmaceutical companies invest in pharmacovigilance resources and solutions to manage the growing demand.
Don’t hesitate to contact our analyst if you have any questions @ https://www.futuremarketinsights.com/ask-question/rep-gb-1107
Key Takeaways from the Pharmacovigilance Market
- The pharmacovigilance industry in the United Kingdom is anticipated to rise sizably, exhibiting a CAGR of 12.1% through 2033, driven by the implementation of advanced artificial intelligence technologies for adverse event monitoring.
- The United States held a 30.9% share of the global pharmacovigilance industry in 2022, primarily attributed to the stringent regulatory framework and the increased focus on drug safety by the Food and Drug Administration.
- With a CAGR of 15.4% over the forecast period, India is predicted to develop rapidly in the pharmacovigilance industry, driven by the government’s initiatives to strengthen its healthcare infrastructure and streamline adverse drug reaction reporting mechanisms.
- In 2022, Japan had a 5.1% share of the pharmacovigilance industry globally, boosted by the country’s increasing focus on drug safety regulations and the implementation of a robust post-marketing surveillance system.
- The pharmacovigilance industry in China is expected to flourish speedily, registering a CAGR of 16.8% over the forecast period, fueled by the government’s efforts to strengthen its regulatory framework and enhance pharmacovigilance practices for ensuring drug safety in a rapidly expanding healthcare market.
- Germany accounted for 6.9% of the global pharmacovigilance industry in 2022, driven by the country’s robust healthcare infrastructure and the focus on efficient adverse drug reaction monitoring through its well-established national pharmacovigilance system.
Your Market, Your Insights: Request Customizations to Optimize Your Pharmacovigilance Market Approach @ https://www.futuremarketinsights.com/customization-available/rep-gb-1107
Competitive Landscape in the Pharmacovigilance Market
In the pharmacovigilance industry, key players, including pharmaceutical companies, regulatory authorities, and specialized service providers, are actively monitoring and assessing the safety of drugs and medical products. They collaborate to detect, evaluate, and manage adverse effects, ensuring patient safety and compliance with regulations. Additionally, these players invest in advanced technologies and data analytics to enhance pharmacovigilance processes and stay at the forefront of drug safety management.
Key Players:
- Accenture Plc.
- Bristol-Myers Squibb
- Clinquest Group B.V.
- Cognizant Technology Solutions
- Covance Inc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc.
- ICON Plc
- iGATE Corporation
- iMED Global Corporation
- inVentiv Health Inc.
- Novartis AG
- PAREXEL International Corporation
- Pfizer Inc.
- Pharmaceutical Product Development LLC. (PPD)
- PRA Health Sciences Inc.
- Quintiles Transnational Holdings Inc.
- Sanofi SA
- Synowledge LLC
- Wipro Ltd.
Key segments
By Phase of Drug Development:
- Preclinical Studies
- Phase I
- Phase II
- Phase III
- Phase IV
By Type of Methods:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
By Service Type Provider:
- In-house Pharmacovigilance
- Contract Outsourcing
Act Now to Explore In-Depth Market Analysis: Get Exclusive Purchase Now to Access @ https://www.futuremarketinsights.com/checkout/1107
By Geography:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube